← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Keystone Nano, Inc.
State College, PA
$4,750,831
Total funding
6
Grants
Funding over time
peak $1.3M · FY2009–23$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,750,831 · 6
By mechanism
R44$4,003,544 · 2
N43$423,391 · 2
U43$223,896 · 1
R43$100,000 · 1
Investigators at Keystone Nano, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Clinical Investigation of the Ceramide NanoLiposome for Advanced Solid Tumors$1,057,443
R44 · FY2015 · CA
Ceraxa (Ceramide NanoLiposome) and Vinblastine For the Improved Treatment of Relapsed or Refractory Acute Myeloid Leukemia$999,628
R44 · FY2022 · CA
Ceraxa (Ceramide NanoLiposome) and Vinblastine For the Improved Treatment of Relapsed or Refractory Acute Myeloid Leukemia$999,628
R44 · FY2023 · CA
Clinical Investigation of the Ceramide NanoLiposome for Advanced Solid Tumors$942,527
R44 · FY2016 · CA
DEVELOPMENT OF SIRNA NANOJACKETS FOR INFLUENZA TREATMENT$224,881
N43 · FY2015 · AI
Targeted siRNA NanoJackets for the Personalized Treatment of Breast Cancer$223,896
U43 · FY2014 · CA
TAS::75 0849::TAS MULTIFUNCTIONAL NANOJACKETS FOR BREAST CANCER TREATMENT$198,510
N43 · FY2010 · CA
Targeting NanoJacketed Doxorubicin to Tumor Sites for Improved Treatment of Breas$100,000
R43 · FY2009 · CA
Clinical Investigation of the Ceramide NanoLiposome for Advanced Solid Tumors$4,318
R44 · FY2019 · CA